In a study using paired tumor samples, the density of Tregs shifted from negative or low at baseline to high after the development of EGFR-TKI resistance in programmed death-ligand 1 (PD-L1)-negative or -positive tumors, indicating an immunosuppressive role of Tregs in oncogene-driven tumors [98]. Here, EGFR is linked to neoplasm.